Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

USPSTF: Recommendation in Screening for AF

JAMA; 2018 Aug 7; US Preventive Services Task Force

The US Preventive Services Task Force (USPSTF) issued a new recommendation statement on screening for atrial fibrillation (AF) with electrocardiography (ECG), finding inadequate evidence to determine whether screening with ECG and subsequent treatment in asymptomatic adults is more effective than usual care. The USPSTF reviewed the evidence on the benefits and harms of screening for AF with ECG in adults aged ≥65 years, the effectiveness of screening with ECG for detecting previously undiagnosed AF compared with usual care, and the benefits and harms of anticoagulant or antiplatelet therapy for the treatment of screen-detected AF in older adults. The USPSTF final recommendation statement states:

  • The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for atrial fibrillation with ECG (I statement).

Citation:

US Preventive Services Task Force. Screening for atrial fibrillation with electrocardiography. US Preventive Services Task Force recommendation statement. JAMA. 2018;320(5):478–484. doi:10.1001/jama.2018.10321.